Canton Strategic Holdings CNTN
NASDAQ CNTN
$2.28 +0.03 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Canton Strategic Holdings (CNTN) Total Liabilities (2020 - 2026)

Canton Strategic Holdings' (CNTN) quarterly Total Liabilities came in at $114.9 million in Q1 2026, up 4538.81% YoY from $2.5 million in Q1 2025, and down 5.25% on a QoQ basis from $121.2 million in Q4 2025.

Analysis

Canton Strategic Holdings (CNTN) Total Liabilities (2020 - 2026) Analysis & Trends

Canton Strategic Holdings (CNTN) has 7 years of Total Liabilities data on file, last reported at $114.9 million in Q1 2026.

  • Quarterly Total Liabilities rose 4538.81% year-over-year to $114.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $114.9 million (up 4538.81% YoY) and the FY2025 annual result came in at $121.2 million, up 4921.6% from the prior year.
  • Total Liabilities retreated to $114.9 million in Q1 2026, from $121.2 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $121.2 million in Q4 2025 to a low of $902348.0 in Q3 2022.
  • A 5-year average of $15.4 million and a median of $1.8 million in 2022 frame the typical range for Total Liabilities.
  • Annual changes were most pronounced in 2022 — Total Liabilities slumped 78.42% — and 2025, when it jumped 4921.6%.
  • Tracing CNTN's Total Liabilities over 5 years: stood at $1.1 million in 2022, then soared by 58.52% to $1.8 million in 2023, then surged by 33.0% to $2.4 million in 2024, then jumped by 4921.6% to $121.2 million in 2025, then decreased by 5.25% to $114.9 million in 2026.
  • The last three Total Liabilities figures came in at $114.9 million (Q1 2026), $121.2 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 7.18 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 10.02 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.62 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 4.20 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 1.72 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 4.00 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 4.20 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 10.03 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.35 Bn
10 Canton Strategic Holdings 493.37 Mn 493.37 Mn - 109.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 109.67 Mn
Mar 31, 2026 114.86 Mn
Dec 31, 2025 121.22 Mn
Sep 30, 2025 1.54 Mn
Jun 30, 2025 2.16 Mn
Mar 31, 2025 2.48 Mn
Dec 31, 2024 2.41 Mn
Sep 30, 2024 2.23 Mn
Jun 30, 2024 1.56 Mn
Mar 31, 2024 1.84 Mn
Dec 31, 2023 1.82 Mn
Sep 30, 2023 1.41 Mn
Jun 30, 2023 1.53 Mn
Mar 31, 2023 1.52 Mn
Dec 31, 2022 1.14 Mn
Sep 30, 2022 902,348.00
Jun 30, 2022 1.21 Mn
Mar 31, 2022 1.75 Mn
Dec 31, 2021 5.31 Mn
Sep 30, 2021 7.14 Mn